APA (7th ed.) Citation

Ossato, A., Damuzzo, V., Baldo, P., Mengato, D., Chiumente, M., & Messori, A. (2023). Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression‐free survival based on reconstructed individual patient data. Wiley.

Chicago Style (17th ed.) Citation

Ossato, Andrea, Vera Damuzzo, Paolo Baldo, Daniele Mengato, Marco Chiumente, and Andrea Messori. Immune Checkpoint Inhibitors as First Line in Advanced Melanoma: Evaluating Progression‐free Survival Based on Reconstructed Individual Patient Data. Wiley, 2023.

MLA (9th ed.) Citation

Ossato, Andrea, et al. Immune Checkpoint Inhibitors as First Line in Advanced Melanoma: Evaluating Progression‐free Survival Based on Reconstructed Individual Patient Data. Wiley, 2023.